Dr Irmgard Irminger-Finger – Chief Scientific Officer/Executive Director PD, PhD (appointed
16 June 2016)
Melbourne, Australia,
15 January 2021: BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) announces that Dr Irmgard Irminger-Finger has stepped down from the board. Dr IrmingerFinger, who resides in Geneva, Switzerland
sure... they were going to get the lung test to be a success in the next 5 months after 5 years of failure and changing their focus to other technology, including a merger with new tech, which caused the share price to go nuts
